Langlara Receives FDA Nod as Interchangeable Lantus Alternative Renal and Urology News 15:08 Wed, 06 May
Lannett, Lanexa Biologics and Sunshine Lake secure FDA approval for Langlara Pharmaceutical Technology 10:21 Tue, 05 May
Lannett Company, Lanexa Biologics and Sunshine Lake Pharma announce FDA Approval of Langlara™ an Interchangeable Biosimilar of Lantus® (insulin glargine) Business Wire (Press Release) 14:17 Mon, 04 May
